A groundbreaking study published in Nature Neuroscience provides new insights into brain cell communication and opens the door to innovative treatment strategies for Alzheimer's disease. The research team identified a novel way to potentially slow down or halt disease progression by manipulating the plexin-B1 protein.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Neuroscience·DateMay 27, 2024
Research from McMaster University found that orienteering exercise can improve spatial memory and delay cognitive decline. Those who ran while orienteering showed greater benefits than those who walked or exercised without navigation. The study suggests that orienteering could be a preventative measure for age-related cognitive decline.
SourceMcMaster University·JournalPLOS ONE·TypeRandomized controlled/clinical trial·DateMay 27, 2024
A new study followed 283 older adults with no memory or thinking problems to examine the factors leading to stopping driving. The research found that female participants were more likely to stop driving than male participants, as well as those who developed cognitive impairment and performed worse on cognitive tests.
SourceAmerican Academy of Neurology·JournalNeurology·DateMay 22, 2024
A new study found that subtle cognitive changes can foreshadow the decision for many seniors to stop driving. Routine cognitive testing may help older adults and their physicians make decisions about driving to maximize safety while preserving independence. Women are more likely to stop driving than men, according to the findings.
SourceWashU Medicine·JournalNeurology·TypeObservational study·DateMay 22, 2024
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A new study at the University of Copenhagen reveals that urolithin A, a naturally occurring substance in pomegranates, can alleviate memory problems and other consequences of dementia. The substance shows promise in improving brain function by removing damaged mitochondria.
SourceUniversity of Copenhagen - The Faculty of Health and Medical Sciences·JournalAlzheimer s & Dementia·DateMay 22, 2024
Researchers have discovered new potential drug targets for Alzheimer's by analyzing the electrical activity and protein levels of individual brain cells. The study found nearly 50 proteins associated with hyperexcitability in Alzheimer's neurons, shedding light on the disease's molecular drivers.
SourceScripps Research Institute·JournalAdvanced Science·DateMay 22, 2024
Scientists have discovered the transporters responsible for delivering essential nutrients choline and ethanolamine to human cells. The study sheds light on the atomic structure of these transporters and their role in distributing micronutrients throughout the body, providing a foundation for new therapeutic approaches.
SourceNational University of Singapore, Yong Loo Lin School of Medicine·JournalNature·TypeExperimental study·DateMay 22, 2024
Researchers have developed an AI algorithm that can track protein clumping under the microscope in real-time, revolutionizing the study of neurodegenerative disorders. The tool helps identify key characteristics of clumped proteins, which can lead to new therapies.
SourceUniversity of Copenhagen - Faculty of Science·JournalNature Communications·DateMay 22, 2024
Research suggests that oxidative stress (OS) may trigger Alzheimer's disease and that enriching brain glutathione (GSH) could be a way forward. Clinical studies indicate GSH depletion in the hippocampus initiates early onset of AD prior to amyloid beta deposition and tau phosphorylation.
SourceIOS Press·JournalJournal of Alzheimer’s Disease·TypeExperimental study·DateMay 21, 2024
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
A Phase III randomized, placebo-controlled trial found that donepezil did not improve memory or other cognitive functions in breast cancer survivors. Despite this, researchers emphasize the need for further trials with different approaches to address cancer-related cognitive impairment.
SourceAtrium Health Wake Forest Baptist·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateMay 20, 2024
A study by Duke and Columbia Universities found that non-white older adults with mild cognitive impairment reside in areas with more environmental injustices than their white peers. The study suggests that location, race, and environmental factors may interact to impact brain health.
SourceIOS Press·JournalJournal of Alzheimer s Disease Reports·TypeMeta-analysis·DateMay 17, 2024
Researchers found that boosting mitochondrial health can combat protein clumping linked to both aging and Alzheimer's. The study identifies a core insoluble proteome enriched with numerous proteins not previously considered, offering new targets for exploration.
SourceBuck Institute for Research on Aging·JournalGeroScience·TypeExperimental study·DateMay 16, 2024
A study by Netherlands Institute for Neuroscience found that certain individuals with Alzheimer's disease processes in their brains did not show clinical symptoms. Gene-expression profiling revealed higher expression of genes related to metallothionein and mitochondrial processes in these 'resilient' individuals.
SourceNetherlands Institute for Neuroscience - KNAW·JournalActa Neuropathologica Communications·DateMay 15, 2024
FutureNeuro, a leading SFI Research Centre, is expanding its research programme with a focus on diagnostics, therapeutics, and digital health. The centre aims to develop precision diagnostics, future treatments, and systems using real-time health data.
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
A new biomarker, miR-519a-3p, has been discovered to detect Alzheimer's disease in its asymptomatic stages. The molecule is linked to the expression of cellular prion protein, which is deregulated in people with neurodegenerative diseases.
SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·TypeExperimental study·DateMay 15, 2024
Researchers discovered the key role of protein Contactin-4 in shaping neurons and its interaction with APP, a gene strongly linked to Alzheimer's disease. The study found that CNTN4 regulates neural elongation and is co-dependent with APP for brain development.
SourceUniversity of Exeter·JournalOpen Biology·TypeExperimental study·DateMay 15, 2024
A University of Saskatchewan researcher is building tiny pseudo-organs from stem cells to help diagnose and treat Alzheimer's disease. These 'mini-brains' more accurately reflect a fully-fledged adult human brain, allowing for closer examination of neurological conditions.
SourceUniversity of Saskatchewan·JournalFrontiers in Cellular Neuroscience·TypeExperimental study·DateMay 14, 2024
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Engineers at the University of California San Diego used a new technique called MUSIC to map out interactions between chromatin and RNA in individual brain cells. The study found that some brain cells age faster and are more prevalent in individuals with Alzheimer's disease, particularly in women.
SourceUniversity of California - San Diego·JournalNature·DateMay 14, 2024
A study from North Carolina State University found that environmentally caused alterations in the genome may contribute to Alzheimer's disease risk, particularly in Black people. The research identified stable epigenetic features that distinguish Alzheimer's brains from those without the disease.
SourceNorth Carolina State University·JournalClinical Epigenetics·TypeData/statistical analysis·DateMay 14, 2024
White and Hispanic people are most likely to be diagnosed with behavioral symptoms of dementia, but also receive potentially harmful drugs. The study found substantial racial disparities in dementia diagnosis and treatment, with non-white patients being underdiagnosed for treatable symptoms.
SourceUniversity of Southern California·JournalJournal of Alzheimer’s Disease·TypeData/statistical analysis·DateMay 14, 2024
A study published by USTC reveals that age-dependent accumulation of Glu-5’tsRNA-CTC impairs mitochondrial protein translation, accelerating brain aging and Alzheimer’s disease. This abnormal accumulation disrupts cristae structure, resulting in reduced synaptic glutamate levels.
SourceUniversity of Science and Technology of China·JournalCell Metabolism·DateMay 13, 2024
Researchers at PNNL have developed a method to control the handedness of peptoid helices, which can be used to design precise drug delivery agents or artificial enzymes. The team's discovery could provide insights into protein assembly and potentially lead to breakthroughs in treating protein folding-related diseases.
SourceDOE/Pacific Northwest National Laboratory·JournalNature Communications·DateMay 9, 2024
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
Researchers found a significant association between neighborhood deprivation and DNA methylation in brain tissue, which may be linked to immune response. The study identified one CpG site (cg26514961, PLXNC1 gene) significantly associated with neighborhood deprivation after controlling for covariates.
SourceImpact Journals LLC·JournalAging-US·TypeRandomized controlled/clinical trial·DateMay 9, 2024
Purdue University researcher Hana Hall explores the role of R-loops in neurodegenerative diseases, including Alzheimer's, by investigating their impact on neuronal aging and DNA damage. Her work aims to understand how R-loop accumulation contributes to cellular stress and damage.
Researchers at UCLA Health discovered a novel, energy-efficient mechanism of working memory that reduces metabolic cost even during sleep. The discovery is published in Nature Communications and may provide an early diagnostic for Alzheimer's disease and related dementia.
SourceUniversity of California - Los Angeles Health Sciences·JournalNature Communications·TypeComputational simulation/modeling·DateMay 8, 2024
A recent CU Anschutz study found that young people with youth-onset diabetes have a higher risk of developing neurodegenerative diseases like Alzheimer's. The study discovered specific blood biomarkers and elevated amyloid protein accumulation in the brains of participants, indicating an early onset AD risk trajectory.
SourceUniversity of Colorado Anschutz Medical Campus·JournalEndocrines·TypeObservational study·DateMay 8, 2024
Three FAU researchers have received $1M in FDOH grants to develop innovative approaches against Alzheimer's disease. Mare Cudic aims to explore the link between glycosylation and neuroinflammation, while Ruth Tappen develops an online screening tool for older drivers with cognitive decline.
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Researchers created a corticolimbic index tool that categorizes Alzheimer's disease into three subtypes based on brain changes. The study found demographic and clinical differences among sex, age at onset, and rate of cognitive decline.
SourceMayo Clinic·JournalJAMA Neurology·DateMay 6, 2024
A study published in Nature Medicine reveals that individuals with two copies of the APOE4 gene develop signs of Alzheimer's disease, with over 95% showing biological characteristics at age 65. The findings suggest a new genetic form of Alzheimer's disease, potentially leading to personalized prevention and treatment strategies.
SourceInstitut de Recerca Sant Pau (Sant Pau Research Institute)·JournalNature Medicine·TypeObservational study·DateMay 6, 2024
A study found that an organ transplant drug, rapamycin, can regulate over-excited neurons and preserve cognitive function in mouse models of Alzheimer's disease and seizures. The research suggests that seizures may accelerate AD progression and that targeting neuron excitability could slow the disease.
SourceUniversity of Pennsylvania School of Medicine·JournalBrain·TypeExperimental study·DateMay 1, 2024
A study led by Universitat Rovira i Virgili reveals the mechanism behind a diet high in saturated fats and Alzheimer's disease, showing that a high-fat diet can worsen insulin-related miRNAs and lead to brain damage.
SourceUniversitat Rovira i Virgili·JournalNutrients·DateApr 29, 2024
A commentary highlights the importance of including nursing home residents in clinical trials to address health equity concerns. The authors propose key elements for successful nursing home clinical trials and emphasize the benefits of conducting research in this setting.
SourceRegenstrief Institute·JournalJournal of the American Geriatrics Society·DateApr 29, 2024
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers identify TRMT10C enzyme causing methylation of ND5 mRNA, leading to mitochondrial dysfunction and reduced energy supply to the brain. Impairment of complex I in the respiratory chain contributes to Alzheimer's disease pathology.
SourceJohannes Gutenberg Universitaet Mainz·JournalMolecular Psychiatry·DateApr 25, 2024
A new nanomaterial has been developed to mimic the behavior of proteins and may lead to effective treatments for Alzheimer's and other neurodegenerative diseases. The nanomaterial alters the interaction between two key proteins in brain cells, potentially providing a powerful therapeutic effect.
SourceUniversity of Wisconsin-Madison·JournalAdvanced Materials·TypeExperimental study·DateApr 25, 2024
Researchers at KTH Royal Institute of Technology have developed a microfluidic device that converts skin cells into neural stem cells, speeding up the process and reducing costs. This advance brings personalized cell-based therapies for Alzheimer's and Parkinson's closer to reality.
SourceKTH, Royal Institute of Technology·JournalAdvanced Science·TypeObservational study·DateApr 24, 2024
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
A global consortium has studied the connection between a specific gene variation and Pick's disease, a rare form of early-onset dementia. The research found that the MAPT H2 genetic variant is associated with an increased risk of Pick's disease in people of European descent.
SourceMayo Clinic·JournalThe Lancet Neurology·DateApr 24, 2024
The Alzheimer's disease treatment landscape is experiencing a significant shift, with numerous potential drugs making their way through clinical trials. Biomarkers have also emerged as a key area of focus, providing valuable information on the drug's impact and allowing for more precise guidance in future trials.
SourceUniversity of Nevada, Las Vegas·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeSystematic review·DateApr 24, 2024
Researchers used state-of-the-art imaging techniques to discover the metabolism driving Alzheimer's disease, suggesting new treatment strategies. Lipid droplet metabolism can malfunction in Alzheimer's, leading to a cycle of stress and inflammation that worsens the disease.
SourceUniversity of California - San Diego·JournalCell Metabolism·DateApr 23, 2024
Researchers used machine learning to analyze over 1.09 million potential metabolite-receptor pairs and predict the likelihood that each interaction contributed to Alzheimer's disease. The study found a protective metabolite called agmatine interacting with a receptor called CA3R in brain cells, reducing CA3R levels and lowering phospho...
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Depletion of axonal mitochondria disrupts autophagy, leading to abnormal protein build-up in neurons. Restoring mitochondrial levels restores autophagy and recovers impaired neuron function.
SourceTokyo Metropolitan University·JournaleLife·DateApr 20, 2024
Researchers at Gladstone Institutes have identified a blood coagulation protein, fibrin, as the culprit behind toxic inflammation and neuron loss after a major head injury. This finding can inform new treatment strategies for traumatic brain injuries, which often lead to dementia, depression, and difficulty concentrating.
SourceGladstone Institutes·JournalJournal of Neuroinflammation·TypeExperimental study·DateApr 19, 2024
The Association for Chemoreception Sciences (AChemS) 46th annual meeting features 62 presentations and 184 accepted posters on various topics including taste transduction, olfactory dysfunction, and social behavior. The conference promises a comprehensive exploration of cutting-edge research with keynote presentations and symposia.
SourceAssociation for Chemoreception Sciences·DateApr 18, 2024
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Scientists at Salk Institute explore the clinical potential of cannabinol (CBN) in treating traumatic brain injury, Alzheimer's disease, and Parkinson's disease. They identify four CBN analogs with improved neuroprotective ability and drug-like efficacy.
Researchers found that ketogenic diets reduced plasma levels of total Tau in females, mitigated elevations in plasma lipids, and improved circulating lipids. However, neither continuous nor intermittent ketogenic diets improved measures of cognitive or motor behavior in the TgF344-AD rat model.
SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateApr 17, 2024
Researchers found that individuals from certain racial and ethnic groups are less likely to be eligible for Alzheimer's disease clinical trials due to lower amyloid levels at early stages of the disease. Amyloid buildup in the brain varies across different populations, contributing to underrepresentation in clinical trials.
SourceKeck School of Medicine of USC·JournalAlzheimer s & Dementia·TypeRandomized controlled/clinical trial·DateApr 17, 2024
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
Scientists at Sanford Burnham Prebys have identified promising links between common HIV drugs and a reduced incidence of Alzheimer's disease. The study analyzed over 225,000 medical records and found that RT inhibitor exposure was associated with a statistically significant reduced incidence and prevalence of AD.
SourceSanford Burnham Prebys·JournalPharmaceuticals·TypeObservational study·DateApr 16, 2024
Researchers investigate how early-stage Alzheimer's disease affects memory formation by examining synaptic connections and amyloid beta. The study aims to understand the role of NMDA receptors in synaptic plasticity and how they might be hijacked by amyloid beta, leading to memory dysfunction.
Researchers aim to understand mechanisms behind high ADRD rates among MENA immigrants, a growing demographic. The study will investigate daily living, stress, genetics, brain health, and cognitive ability, using MRI-based imaging and cognitive assessments.
A new study reveals that people with Down syndrome are more prone to developing Alzheimer's disease due to the presence of an extra chromosome 21, which leads to increased amyloid deposits. As a result, cognitive decline occurs in their 50s, whereas autosomal dominant Alzheimer's typically starts later in life.
SourceWashU Medicine·JournalThe Lancet Neurology·TypeObservational study·DateApr 16, 2024
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
Researchers identified a novel mechanism where APP-CTFs disrupt organellar communication, interfering with cellular homeostasis and leading to endolysosomal dysfunction. This finding suggests that preventing APP-CTF accumulation could be crucial for developing new AD treatments.
SourceVlaams Instituut voor Biotechnologie·JournalDevelopmental Cell·TypeExperimental study·DateApr 15, 2024
A recent Mayo Clinic study investigated lucid episodes in people living with later stages of dementia, revealing that 75% were reported to have Alzheimer's Disease. The researchers identified distinct patterns or types of lucid episodes, suggesting they may be related to the level of cognition and circumstances surrounding the episode....
SourceMayo Clinic·JournalAlzheimer’s & Dementia·DateApr 11, 2024
Researchers found that geraniol reduces oxidative stress and neuroinflammation-mediated cognitive impairment in a mouse aging model. Geraniol treatment improved spatial learning and memory by enhancing anti-oxidant and anti-inflammatory effects.
SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateApr 10, 2024
A new study found a link between midlife racial discrimination and increased levels of Alzheimer's disease markers, including phosphorylated tau181 and neurofilament light, in older age. Researchers analyzed data from 255 Black Americans over 17 years, revealing that chronic stress from racism contributed to dementia risk.
SourceAtrium Health Wake Forest Baptist·JournalAlzheimer s & Dementia·DateApr 10, 2024
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
Researchers at Columbia University Irving Medical Center have discovered a genetic variant in the fibronectin gene that protects against Alzheimer's disease. The variant, found in APOEe4 carriers, reduces the odds of developing Alzheimer's by up to 70% and may help prevent or treat the disease.
SourceColumbia University Irving Medical Center·JournalActa Neuropathologica·TypeObservational study·DateApr 10, 2024
Concordia researchers use network analysis to study cognitive decline, identifying key variables that predict subtle changes in brain function. Executive function and processing speed are found to be strongly influential, with age affecting cognition differently for those with mild cognitive impairment or Alzheimer's disease.
SourceConcordia University·JournalCortex·TypeData/statistical analysis·DateApr 9, 2024
Scientists discovered that tiny brain bubbles called small extracellular vesicles carry more complete instructions for altering cellular function than previously thought. Researchers found nearly 80% of identified mRNAs were full-length, allowing them to be transcribed by recipient cells into viable proteins.
SourceSanford Burnham Prebys·JournalCell Reports·TypeExperimental study·DateApr 8, 2024
A traumatic brain injury quadruples the risk of developing dementia and neurodegenerative diseases like ALS. USC scientists used lab-grown human brain structures called organoids to study TBI's effects. They identified a gene, KCNJ2, that helps protect nerve cells against injury.
SourceKeck School of Medicine of USC·JournalCell Stem Cell·TypeExperimental study·DateApr 4, 2024
A study published in PNAS reveals the structure of a protein linked to neurodegenerative disease Niemann-Pick type C, which accumulates cholesterol within cellular compartments. The research sheds light on the complex mechanism of cholesterol distribution and its role in maintaining optimal levels.
SourceAarhus University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateApr 3, 2024
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
A new study published in Neurology found that earlier menopause and higher cardiovascular risk are associated with increased risk of thinking and memory problems later. Women who experienced earlier menopause had lower cognitive scores compared to their male counterparts, especially those with high cardiovascular risk.
SourceAmerican Academy of Neurology·JournalNeurology·DateApr 3, 2024
A recent study published in Annals of Neurology suggests that midlife stressful events may be a risk factor for developing Alzheimer's disease in older ages. Researchers found associations between stress and higher levels of beta-amyloid protein, neuroinflammation, and brain atrophy, particularly in men.
SourceBarcelona Institute for Global Health (ISGlobal)·JournalAnnals of Neurology·TypeObservational study·DateApr 2, 2024